Printer Friendly

Dermoscopic Criteria Identified for Diagnosing Melanoma in Situ; Most frequent dermoscopic criteria for MIS are regression, atypical network, irregular dots/globules.

FRIDAY, Feb. 23, 2018 (HealthDay News) -- The most frequent dermoscopic criteria for melanoma in situ (MIS) are regression, atypical network, and irregular dots and/or globules, according to a study published online Feb. 21 in JAMA Dermatology.

Aimilios Lallas, Ph.D., from Aristotle University in Thessaloniki, Greece, and colleagues conducted a diagnostic accuracy study with retrospective patient enrollment in three centers, including 1,285 individuals with histopathologically diagnosed MIS or other flat, pigmented skin tumors. Three independent investigators evaluated dermoscopic images of MIS and other flat pigmented skin tumors for the presence of predefined criteria.

The researchers found that 25.3 percent of the lesions were MIS. The most frequent dermoscopic criteria for MIS were regression, atypical network, and irregular dots and/or globules (92.9, 85.5, and 50.2 percent, respectively). Five main positive indicators of MIS were identified in multivariate analysis: atypical network, regression, irregular hyperpigmented areas, prominent skin markings, and angulated lines (3.7-, 4.7-, 5.4-, 3.4-, and 2.2-fold, respectively). Two of these criteria remained potent MIS indicators when compared with excised nevi: irregular hyperpigmented areas and prominent skin markings (4.3- and 2.7-fold, respectively).

"Clinicians should take into consideration the aforementioned dermoscopic indicators for the diagnosis of MIS," the authors write.

Abstract/Full Text Editorial (subscription or payment may be required)

COPYRIGHT 2018 HealthDay
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Physician's Briefings
Date:Feb 23, 2018
Words:221
Previous Article:Cognition Deficits Seen in Children With Chronic Kidney Disease; Children with less severe CKD and kidney transplant had higher full-scale IQ than...
Next Article:Private Insurance Coverage of Infused Chemo Varies by Setting; Better reimbursement at hospital outpatient depts, even though drug-level costs lower...
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |